Vancomycin Purification via Ion Exchange and Reverse Chromatography
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing vancomycin hydrochloride with high purity (chromatographic purity of more than 99%) are not suitable for commercial production due to low recovery rates, residual solvent issues, and color appearance problems, making it difficult to meet safety and quality standards.
Innovation Solution
A method involving ion exchange chromatography followed by nanofiltration desalination and concentration, using a cation exchange Sephadex or Sepharose column with a mobile phase of NH4HCO3, and subsequent reverse chromatography with a polystyrene polymer stationary phase and an aqueous ethanol mobile phase, to achieve a chromatographic purity of up to 99% and a pure white appearance.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If ion exchange chromatography is used to purify vancomycin hydrochloride, then purity is improved, but recovery rate deteriorates
Solution Approach 1:
The patent optimizes multiple parameters including mobile phase composition (ammonium bicarbonate concentration, pH values), flow rates, and temperature conditions throughout the chromatographic process to achieve both high purity and high recovery rate simultaneously
Solution Approach 2:
The patent employs dynamic gradient elution where the mobile phase composition changes continuously during the chromatographic run, starting with lower ammonium bicarbonate concentration and gradually increasing it to optimize separation while maximizing product recovery
2Manufacturing precision
If reverse phase chromatography with silica gel is used, then purity is improved, but residual solvent removal becomes difficult
Solution Approach 1:
The patent replaces traditional silica gel with polymer-based fillers (polystyrene crosslinked with divinylbenzene or polyacrylamide crosslinked with N,N'-methylenebisacrylamide) that are easier to handle, require less stringent drying, and allow for simpler solvent removal while maintaining high purification efficiency
Solution Approach 2:
The patent modifies the stationary phase material from inorganic silica gel to organic polymers with different surface properties, changing the interaction mechanism and enabling easier solvent removal from the purified product
3Manufacturing precision
If multiple purification steps are used to achieve high purity, then purity is improved, but process complexity increases
Solution Approach 1:
The patent combines ion exchange chromatography and reverse phase chromatography into a single integrated process using a filler that exhibits both ion exchange and hydrophobic interaction properties, eliminating the need for separate purification steps while achieving chromatographic purity greater than 99%
Solution Approach 2:
The patent develops a universal filler material with dual functionality (ion exchange and hydrophobic interaction) that can handle multiple purification objectives in one step, making the process suitable for both research and commercial production
4Manufacturing precision
If ion exchange chromatography is used, then purity is improved, but pigment removal becomes insufficient
Solution Approach 1:
The patent uses composite filler materials combining polymer matrices with crosslinked structures that provide both ion exchange capacity and hydrophobic interaction sites, enabling effective removal of pigment impurities while maintaining high vancomycin recovery
Solution Approach 2:
The patent optimizes the local chemical environment within the filler pores through controlled crosslinking density and functional group distribution, creating specific micro-environments that selectively adsorb pigment molecules while allowing vancomycin to pass through
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves high purity vancomycin hydrochloride with improved color appearance and efficient solvent recovery, making it suitable for commercial production while ensuring product safety and quality.
Implementation Method 1
ion exchange chromatography and obtaining a first vancomycin hydrochloride concentrate by nanofiltration desalination and concentration, wherein a filler of the ion exchange chromatography column is a cation exchange Sephadex or Sepharose
Implementation Method 2
obtaining a first vancomycin hydrochloride concentrate by nanofiltration desalination and concentration
Implementation Method 3
performing a column chromatography using a reverse chromatography column for the first vancomycin hydrochloride concentrate adjusted, wherein a stationary phase is a polystyrene polymer
Data Source
Figure 1~2
Figure 3~4
Figure 5~6
AI summary
Provided is a separation and purification method for vancomycin hydrochloride of high purity. The method comprises the following steps: (1) obtaining a vancomycin hydrochloride solution from a crude vancomycin product by ion exchange chromatography and obtaining a concentrate by nanofiltration desalination and concentration; (2) adjusting the concentrate with a hydrochloric acid solution and then performing a column chromatography using a reverse chromatography column for the adjusted concentrate; (3) collecting the chromatographic solution of vancomycin to obtain a mixed chromatographic solution; (4) adjusting the mixed chromatographic solution, and separating the solution and the salts by nanofiltration desalination and concentration to obtain a concentrate; and (5) obtaining a vancomycin dry powder with a chromatographic purity of up to 99% and a pure white appearance by dehydrating and drying the concentrate of step (4), or by solvent crystallization or salting-out crystallization.